JP2021525537A5 - - Google Patents
Info
- Publication number
- JP2021525537A5 JP2021525537A5 JP2020567523A JP2020567523A JP2021525537A5 JP 2021525537 A5 JP2021525537 A5 JP 2021525537A5 JP 2020567523 A JP2020567523 A JP 2020567523A JP 2020567523 A JP2020567523 A JP 2020567523A JP 2021525537 A5 JP2021525537 A5 JP 2021525537A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide complex
- cancer
- trimer
- complex according
- trimer polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18382401.0 | 2018-06-06 | ||
| EP18382401 | 2018-06-06 | ||
| PCT/EP2019/064864 WO2019234187A1 (en) | 2018-06-06 | 2019-06-06 | Trimeric polypeptide complexes and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021525537A JP2021525537A (ja) | 2021-09-27 |
| JP2021525537A5 true JP2021525537A5 (enExample) | 2022-06-14 |
| JP7557377B2 JP7557377B2 (ja) | 2024-09-27 |
Family
ID=62716010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020567523A Active JP7557377B2 (ja) | 2018-06-06 | 2019-06-06 | 三量体ポリペプチド複合体およびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12454577B2 (enExample) |
| EP (1) | EP3802601A1 (enExample) |
| JP (1) | JP7557377B2 (enExample) |
| CN (1) | CN112566939A (enExample) |
| WO (1) | WO2019234187A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3177098A1 (en) * | 2020-06-05 | 2021-12-09 | Pieris Pharmaceuticals Gmbh | Multimeric immunomodulator targeting 4-1bb |
| WO2021249010A1 (en) * | 2020-06-10 | 2021-12-16 | Sichuan Clover Biopharmaceuticals, Inc. | Coronavirus diagnostic compositions, methods, and uses thereof |
| EP3944877A1 (en) * | 2020-07-29 | 2022-02-02 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Nanobodies sars-cov2 |
| WO2022023484A1 (en) * | 2020-07-29 | 2022-02-03 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Therapeutic and diagnostic vhh antibodies against sars-cov-2 and methods for their enhancement |
| EP3957650A1 (en) | 2020-08-17 | 2022-02-23 | Themis Bioscience GmbH | Co-stimulatory 4-1bbl ectodomain polypeptides for immunomodulation |
| US20240092942A1 (en) * | 2021-03-05 | 2024-03-21 | Leadartis, S.L. | Trimeric polypeptides and uses thereof in the treatment of cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
| NZ261571A (en) | 1993-02-04 | 1997-03-24 | Denzyme Aps | Producing correctly folded proteins using multiple denaturation and renaturation cycles |
| ES2701445T3 (es) | 2010-10-15 | 2019-02-22 | Leadartis S L | Generación de complejos polipeptídicos multifuncionales y multivalentes mediante el dominio de trimerización del colágeno XVIII |
| MX380176B (es) | 2014-04-07 | 2025-03-12 | Chugai Pharmaceutical Co Ltd | Molecula ligada a antigeno inmunoactivada. |
| ES2910668T3 (es) | 2015-12-11 | 2022-05-13 | Leadartis S L | Constructos de fusión de cadena sencilla que comprenden fragmentos de anticuerpos multiméricos fusionados con dominios de trimerización de colágeno |
| BR112018071612A2 (pt) | 2016-04-22 | 2019-02-19 | Alligator Bioscience Ab | polipeptídeos biespecíficos inovadores contra cd137 |
-
2019
- 2019-06-06 CN CN201980052447.4A patent/CN112566939A/zh active Pending
- 2019-06-06 WO PCT/EP2019/064864 patent/WO2019234187A1/en not_active Ceased
- 2019-06-06 EP EP19731177.2A patent/EP3802601A1/en active Pending
- 2019-06-06 US US16/972,654 patent/US12454577B2/en active Active
- 2019-06-06 JP JP2020567523A patent/JP7557377B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10584152B2 (en) | Binding proteins based on di-ubiquitin muteins and methods for generation | |
| AU2016295024B2 (en) | Her2 binding proteins based on di-ubiquitin muteins | |
| JP2019531704A5 (enExample) | ||
| JP2020505034A5 (enExample) | ||
| JP2023506452A5 (enExample) | ||
| JP2020517294A5 (enExample) | ||
| CN114539411B (zh) | 一种ror1抗体或其抗原结合片段 | |
| JP2016516789A5 (enExample) | ||
| JP2017140051A5 (enExample) | ||
| WO2009142773A4 (en) | Multivalent fibronectin based scaffold domain proteins | |
| JP2019511904A5 (enExample) | ||
| AU2014314214B2 (en) | Binding polypeptides having a mutated scaffold | |
| US20210206847A1 (en) | Igg1 fc monomer and application thereof | |
| JP2023521147A5 (enExample) | ||
| JP2022502015A5 (enExample) | ||
| JP2019535315A5 (enExample) | ||
| JP2023532807A5 (enExample) | ||
| EP3253785A1 (en) | Novel egfr binding proteins | |
| JP2024543043A5 (enExample) | ||
| CA3229160A1 (en) | Bispecific tetravalent antibody targeting egfr and her3 | |
| JP2025512431A5 (enExample) | ||
| CN103675294A (zh) | 新的肿瘤血清标志物及其应用 | |
| JP2024502371A5 (enExample) | ||
| CN119431572B (zh) | 抗vim纳米抗体及其应用 | |
| Chen et al. | Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitro |